| 产品名称 | ReVacc Scientific P11A48 | Pseudovirus_RSV Fusion with Luciferase Reporter (A2 strain) |
|---|---|
| 目录号 | P11A48 |
| 别名 | Pseudovirus_RSV Fusion with Luciferase Reporter (A2 strain) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| P11A48 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific P11A48 | Pseudovirus_RSV Fusion with Luciferase Reporter (A2 strain)
品名:Pseudovirus_RSV Fusion with Luciferase Reporter (A2 strain)
货号:P11A48
品牌:ReVacc Scientific
规格:200 μl; 1000 μl
产品描述
Organism:Human respiratory syncytial virus (RSV) isolate A2 strain
This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry the full-length fusion (F) protein of Human respiratory syncytial virus (RSV) isolate A2 strain (UniProtKB/Swiss-Prot: P03420.1, with prefusion-stabilizing mutations). RSV is a respiratory virus with fusion (F) protein as the major target of neutralizing antibodies/vaccine-elicited sera. As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing that the starting 2-fold diluted pseudovirus generates signal ~ 10,000-fold higher than uninfected control (cell alone as background in blue). Three known neutralizing mAbs (D25, 101F and MPE8) were used to validate its neutralizing activity against this pseudovirus. See picture.